469 related articles for article (PubMed ID: 22309388)
1. Prostaglandin E1 dose-dependently promotes stability of atherosclerotic plaque in a rabbit model.
Bai W; Zheng X; Zhou L; Li H
Can J Physiol Pharmacol; 2012 Feb; 90(2):131-9. PubMed ID: 22309388
[TBL] [Abstract][Full Text] [Related]
2. Traditional Chinese medication Tongxinluo dose-dependently enhances stability of vulnerable plaques: a comparison with a high-dose simvastatin therapy.
Zhang L; Liu Y; Lu XT; Wu YL; Zhang C; Ji XP; Wang R; Liu CX; Feng JB; Jiang H; Xu XS; Zhao YX; Zhang Y
Am J Physiol Heart Circ Physiol; 2009 Dec; 297(6):H2004-14. PubMed ID: 19801495
[TBL] [Abstract][Full Text] [Related]
3. Effect of Si-Miao-Yong-An on the stability of atherosclerotic plaque in a diet-induced rabbit model.
Peng L; Li M; Xu YZ; Zhang GY; Yang C; Zhou YN; Li LJ; Zhang JP
J Ethnopharmacol; 2012 Aug; 143(1):241-8. PubMed ID: 22750436
[TBL] [Abstract][Full Text] [Related]
4. Aqueous extract of rhubarb stabilizes vulnerable atherosclerotic plaques due to depression of inflammation and lipid accumulation.
Liu Y; Yan F; Liu Y; Zhang C; Yu H; Zhang Y; Zhao Y
Phytother Res; 2008 Jul; 22(7):935-42. PubMed ID: 18384190
[TBL] [Abstract][Full Text] [Related]
5. [Effects of Tongxinluo and Simvastatin on the stabilization of vulnerable atherosclerotic plaques of aorta in aortic atherosclerosis and molecular mechanism thereof: a comparative study with rabbits].
Li Z; Yang YJ; Qin XW; Ruan YM; Chen X; Meng L; Zhang HD
Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(44):3146-50. PubMed ID: 17313769
[TBL] [Abstract][Full Text] [Related]
6. Probucol attenuates inflammation and increases stability of vulnerable atherosclerotic plaques in rabbits.
Li T; Chen W; An F; Tian H; Zhang J; Peng J; Zhang Y; Guo Y
Tohoku J Exp Med; 2011 Sep; 225(1):23-34. PubMed ID: 21852751
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of co-administration of atorvastatin and endothelin-1 receptor antagonist on the progression of atherosclerosis in rabbit.
Sun Y; Liu J; Yang B; Sai X; Li T; Wang D; Zhou R
APMIS; 2014 Jun; 122(6):556-64. PubMed ID: 24164644
[TBL] [Abstract][Full Text] [Related]
8. Progression and Characterization of the Accelerated Atherosclerosis in Iliac Artery of New Zealand White Rabbits: Effect of Simvastatin.
Kanshana JS; Khanna V; Singh V; Jain M; Misra A; Kumar S; Farooqui M; Barthwal MK; Dikshit M
J Cardiovasc Pharmacol; 2017 May; 69(5):314-325. PubMed ID: 28207427
[TBL] [Abstract][Full Text] [Related]
9. Statin therapy alone and in combination with an acyl-CoA:cholesterol O-acyltransferase inhibitor on experimental atherosclerosis.
Worthley SG; Helft G; Corti R; Worthley MI; Chew DP; Fayad ZA; Zaman AG; Fallon JT; Fuster V; Badimon JJ
Pathophysiol Haemost Thromb; 2007; 36(1):9-17. PubMed ID: 18332609
[TBL] [Abstract][Full Text] [Related]
10. Effect of minocycline on carotid atherosclerotic plaques.
Gao J; Gao X; Pan S
Neurol Res; 2013 Oct; 35(8):844-50. PubMed ID: 23676309
[TBL] [Abstract][Full Text] [Related]
11. Poly(ADP-ribose) polymerase inhibition reduces atherosclerotic plaque size and promotes factors of plaque stability in apolipoprotein E-deficient mice: effects on macrophage recruitment, nuclear factor-kappaB nuclear translocation, and foam cell death.
Oumouna-Benachour K; Hans CP; Suzuki Y; Naura A; Datta R; Belmadani S; Fallon K; Woods C; Boulares AH
Circulation; 2007 May; 115(18):2442-50. PubMed ID: 17438151
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of Toll-Like Receptors 2, 3, 4, and 8 Is Correlated to the Vascular Atherosclerotic Process in the Hyperlipidemic Rabbit Model: The Effect of Statin Treatment.
Kapelouzou A; Giaglis S; Peroulis M; Katsimpoulas M; Moustardas P; Aravanis CV; Kostakis A; Karayannakos PE; Cokkinos DV
J Vasc Res; 2017; 54(3):156-169. PubMed ID: 28478461
[TBL] [Abstract][Full Text] [Related]
13. Effect of lipid-lowering therapy with atorvastatin on atherosclerotic aortic plaques: a 2-year follow-up by noninvasive MRI.
Yonemura A; Momiyama Y; Fayad ZA; Ayaori M; Ohmori R; Kihara T; Tanaka N; Nakaya K; Ogura M; Taniguchi H; Kusuhara M; Nagata M; Nakamura H; Tamai S; Ohsuzu F
Eur J Cardiovasc Prev Rehabil; 2009 Apr; 16(2):222-8. PubMed ID: 19242355
[TBL] [Abstract][Full Text] [Related]
14. An animal model of atherosclerotic plaque disruption and thrombosis in rabbit using pharmacological triggering to plaques induced by perivascular collar placement.
Sun X; Cao W; Cui J; Wang L; Ma L; Wang T; Peng C; Tian Z; Shi S; Guo S; Tian Y
Cardiovasc Pathol; 2013; 22(4):264-9. PubMed ID: 23452613
[TBL] [Abstract][Full Text] [Related]
15. Oral rapamycin attenuates inflammation and enhances stability of atherosclerotic plaques in rabbits independent of serum lipid levels.
Chen WQ; Zhong L; Zhang L; Ji XP; Zhang M; Zhao YX; Zhang C; Zhang Y
Br J Pharmacol; 2009 Mar; 156(6):941-51. PubMed ID: 19239473
[TBL] [Abstract][Full Text] [Related]
16. Ghrelin inhibits atherosclerotic plaque angiogenesis and promotes plaque stability in a rabbit atherosclerotic model.
Wang L; Chen Q; Ke D; Li G
Peptides; 2017 Apr; 90():17-26. PubMed ID: 28189525
[TBL] [Abstract][Full Text] [Related]
17. Melatonin inhibits macrophage infiltration and promotes plaque stabilization by upregulating anti-inflammatory HGF/c-Met system in the atherosclerotic rabbit: USPIO-enhanced MRI assessment.
Hu ZP; Fang XL; Sheng B; Guo Y; Yu YQ
Vascul Pharmacol; 2020 Apr; 127():106659. PubMed ID: 32068091
[TBL] [Abstract][Full Text] [Related]
18. Interleukin 18 binding protein (IL18-BP) inhibits neointimal hyperplasia after balloon injury in an atherosclerotic rabbit model.
Li JM; Eslami MH; Rohrer MJ; Dargon P; Joris I; Hendricks G; Baker S; Cutler BS
J Vasc Surg; 2008 May; 47(5):1048-57. PubMed ID: 18455646
[TBL] [Abstract][Full Text] [Related]
19. Antiatherosclerotic effects of the novel angiotensin receptor antagonist Fimasartan on plaque progression and stability in a rabbit model: a double-blind placebo-controlled trial.
Lee JY; Lee CW; Kim WJ; Ahn JM; Park DW; Kang SJ; Lee SW; Kim YH; Son WC; Jung S; Park SW; Park SJ
J Cardiovasc Pharmacol; 2013 Aug; 62(2):229-36. PubMed ID: 23615162
[TBL] [Abstract][Full Text] [Related]
20. Ezetimibe reduces plaque inflammation in a rabbit model of atherosclerosis and inhibits monocyte migration in addition to its lipid-lowering effect.
Gómez-Garre D; Muñoz-Pacheco P; González-Rubio ML; Aragoncillo P; Granados R; Fernández-Cruz A
Br J Pharmacol; 2009 Apr; 156(8):1218-27. PubMed ID: 19222481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
